PIN

Sonoco Raises First-Quarter 2023 Financial Guidance

Retrieved on: 
Tuesday, March 21, 2023

HARTSVILLE, S.C., March 21, 2023 (GLOBE NEWSWIRE) -- Sonoco Products Company (NYSE: SON), a diversified global packaging leader, today provided updated first-quarter 2023 earnings guidance and announced its earnings release date and investor conference call information.

Key Points: 
  • HARTSVILLE, S.C., March 21, 2023 (GLOBE NEWSWIRE) -- Sonoco Products Company (NYSE: SON), a diversified global packaging leader, today provided updated first-quarter 2023 earnings guidance and announced its earnings release date and investor conference call information.
  • The press release and management presentation will be issued after the market closes on Monday, May 1, 2023.
  • The live conference call and a corresponding presentation can be accessed via the Company's Investor Relations website at https://investor.sonoco.com .
  • A replay of the conference call and webcast will be archived on the Company's Investor Relations website for at least 30 days.

Lindsay Corporation Announces Second Quarter Fiscal 2023 Earnings Conference Call and Webcast

Retrieved on: 
Tuesday, March 21, 2023

Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today announced it plans to release financial results for its second quarter ended February 28, 2023 before the market opens on Tuesday, April 4, 2023.

Key Points: 
  • Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today announced it plans to release financial results for its second quarter ended February 28, 2023 before the market opens on Tuesday, April 4, 2023.
  • Participants who do not wish to pre-register may dial (833) 535-2202 (U.S.), (412) 902-6745 (international), or (866) 605-3852 (Canada) and request the Lindsay Corporation call.
  • Additionally, the conference call will be simulcast live on the Internet and can be accessed via the investor relations section of the Company's website, www.lindsay.com .
  • Replays of the conference call will remain available on the Company’s website until the next quarterly earnings release.

VNET Reports Unaudited Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Tuesday, March 21, 2023

BEIJING, March 21, 2023 /PRNewswire/ -- VNET Group, Inc. (Nasdaq: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2022.

Key Points: 
  • BEIJING, March 21, 2023 /PRNewswire/ -- VNET Group, Inc. (Nasdaq: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2022.
  • "We concluded a challenging 2022 with solid fourth quarter results, achieving meaningful development on a broad scale," said Jeff Dong, Chief Executive Officer of VNET.
  • Tim Chen, Chief Financial Officer of VNET, commented, "We delivered a resilient performance in the fourth quarter of 2022, with year-over-year revenue growth of 7.7% and adjusted EBITDA margin of 22.6%.
  • Retail IDC MRR[2] per cabinet increased to RMB9,371 in the fourth quarter of 2022, compared to RMB9,287 in the third quarter of 2022 and RMB9,301 in the fourth quarter of 2021.

Agile Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on Wednesday, March 22, 2023

Retrieved on: 
Tuesday, March 21, 2023

PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 financial results after the market close on Wednesday, March 22, 2023.

Key Points: 
  • PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 financial results after the market close on Wednesday, March 22, 2023.
  • Following the release, the Company will host a live conference call and webcast at 4:30 p.m.
  • ET to discuss the Company’s financial results and provide a business update.
  • A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations .

Semantix Announces Date of fourth quarter and Full Year 2022 Financial Results

Retrieved on: 
Tuesday, March 21, 2023

SÃO PAULO, Brazil, March 21, 2023 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX), a leading Latin American end-to-end data and AI platform provider, today announced it will release its financial results for the fourth quarter of 2022, which ended on December 31, 2022, before the U.S. financial markets open on Tuesday, March 28th, 2023.

Key Points: 
  • SÃO PAULO, Brazil, March 21, 2023 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX), a leading Latin American end-to-end data and AI platform provider, today announced it will release its financial results for the fourth quarter of 2022, which ended on December 31, 2022, before the U.S. financial markets open on Tuesday, March 28th, 2023.
  • On the same day, Semantix will host a conference call to discuss its financial results.
  • The conference call will begin at 8:30 a.m. Eastern Time on March 28th, 2023 and will be webcast live on Semantix`s Investor Relations website at ir.semantix.ai/news-events/events .
  • A replay of the conference call webcast will be archived on Semantix`s Investor Relations website for at least 30 days.

EQS-News: Evotec SE to announce preliminary financial results for fiscal year 2022 on 28 March 2023

Retrieved on: 
Tuesday, March 21, 2023

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its preliminary financial results for 2022 on Tuesday, 28 March 2023.

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its preliminary financial results for 2022 on Tuesday, 28 March 2023.
  • The Company is going to hold a conference call to discuss the results as well as provide an update on its performance.
  • To join the audio webcast and to access the presentation slides you will find a link on our homepage www.evotec.com shortly before the event.
  • The on-demand version of the webcast will be available on our website: https://www.evotec.com/en/investor-relations/publications .

17 Education & Technology Group Inc. to Report Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results on March 27, 2023

Retrieved on: 
Tuesday, March 21, 2023

BEIJING, China, March 21, 2023 (GLOBE NEWSWIRE) -- 17 Education & Technology Group Inc. (NASDAQ: YQ) (“17EdTech” or the “Company”), a leading education technology company in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022, on March 27, 2023 after the close of U.S. markets.

Key Points: 
  • BEIJING, China, March 21, 2023 (GLOBE NEWSWIRE) -- 17 Education & Technology Group Inc. (NASDAQ: YQ) (“17EdTech” or the “Company”), a leading education technology company in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022, on March 27, 2023 after the close of U.S. markets.
  • The Company’s management will hold an earnings conference call on Monday, March 27, 2023 at 9:00 p.m. U.S. Eastern Time (Tuesday, March 28, 2022 at 9:00 a.m. Beijing time).
  • Please note that all participants will need to preregister online prior to the call to receive the dial-in details.
  • Upon registration, you will receive a confirmation email containing participant dial-in numbers, and PIN number.

HUYA Inc. Reports Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results

Retrieved on: 
Tuesday, March 21, 2023

GUANGZHOU, China, March 21, 2023 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game live streaming platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022.

Key Points: 
  • GUANGZHOU, China, March 21, 2023 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game live streaming platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022.
  • Average mobile MAUs[2]of Huya Live for the fourth quarter of 2022 was 85.5 million, compared with 85.4 million for the same period of 2021.
  • Average mobile MAUs of Huya Live in fiscal year 2022 was 84.3 million, compared with 80.9 million in 2021.
  • Average quarterly paying users of Huya Live in fiscal year 2022 was 5.6 million, compared with 5.8 million in 2021.

Strategic Education, Inc. Schedules First Quarter 2023 Results Conference Call and Confirms Date and Location for 2023 Investor and Analyst Day

Retrieved on: 
Monday, March 20, 2023

Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced that it will host a conference call to discuss its first quarter results on Thursday, April 27, 2023 at 10:00 a.m.

Key Points: 
  • Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced that it will host a conference call to discuss its first quarter results on Thursday, April 27, 2023 at 10:00 a.m.
  • A news release outlining the results will be issued before the market opens the same day.
  • Strategic Education has finalized plans for its 2023 Investor and Analyst Day, which will be held on Tuesday, November 7, 2023 at 8:00 a.m.
  • The Investor and Analyst Day registration details will be available at www.strategiceducation.com in the Investor Relations section by September 1, 2023.

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2022 Financial Results on March 27, 2023

Retrieved on: 
Monday, March 20, 2023

CHARLOTTESVILLE, Va. and CARMEL, Ind., March 20, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, today announced that the Company will report fourth quarter and year-end 2022 financial results on Monday, March 27, 2023.

Key Points: 
  • CHARLOTTESVILLE, Va. and CARMEL, Ind., March 20, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, today announced that the Company will report fourth quarter and year-end 2022 financial results on Monday, March 27, 2023.
  • The Company will host a conference call and live audio webcast at 8:00 a.m.
  • ET to provide a business and financial update.
  • To participate in the live conference call, please register using this link .